|
561 |
Quarterly loss of Ranbaxy reduced |
Download (33.02 KB)  |
06/02/2014 |
|
562 |
Sets aside Rs. 257.4cr for impact of USFDA ban |
Download (77.88 KB) |
06/02/2014 |
|
563 |
Ranbaxy net loss narrows |
Download (30 KB) |
06/02/2014 |
|
564 |
GSK posts $8.8 billion profit |
Download (68.87 KB) |
06/02/2014 |
|
565 |
Relief for Ranbaxy laboratories but questions still remain |
Download (60.19 KB) |
06/02/2014 |
|
566 |
Neuland labs profit doubles in Q3 |
Download (21.58 KB) |
06/02/2014 |
|
567 |
Ranbaxy says Toansa unit ban will hit US business by 10-12% |
Download (38.28 KB) |
06/02/2014 |
|
568 |
By 2014-end we will reach 1 mn outlets |
Download (70.84 KB) |
06/02/2014 |
|
569 |
Elder Pharma to flex muscle in nutraceuticals |
Download (35.18 KB) |
05/02/2014 |
|
570 |
Suven life sciences profit up |
Download (19.14 KB) |
05/02/2014 |
|
571 |
Lupin vaitals in good shape |
Download (56.08 KB) |
04/02/2014 |
|
572 |
Daiichi may step in to resolve Ranbaxy US FDA issues |
Download (59.23 KB) |
04/02/2014 |
|
573 |
Mylan brings breast cancer drug to India |
Download (25.25 KB) |
04/02/2014 |
|
574 |
Lupin net up 42% acquires Nanomi of Netherlands |
Download (48.53 KB) |
04/02/2014 |
|
575 |
Novartis to Axe 4000 |
Download (25.43 KB) |
03/02/2014 |
|
576 |
The swiss connection |
Download (89.11 KB) |
03/02/2014 |
|
577 |
The swiss connection |
Download (89.11 KB) |
03/02/2014 |
|
578 |
Mylan India to sell gilead drugs |
Download (30.39 KB) |
01/02/2014 |
|
579 |
Glenmark gets nod to merge arms |
Download (31.42 KB) |
01/02/2014 |
|
580 |
Daiichi pledges action on Ranbaxy production issues |
Download (32.29 KB) |
01/02/2014 |
औषध विभाग
Department of
